Home Preliminary assessment of an injectable extracellular matrix from decellularized bovine myocardial tissue
Article
Licensed
Unlicensed Requires Authentication

Preliminary assessment of an injectable extracellular matrix from decellularized bovine myocardial tissue

  • Hatice Ercan , Ayşe Eser Elçin and Yaşar Murat Elçin ORCID logo EMAIL logo
Published/Copyright: May 27, 2021
Become an author with De Gruyter Brill

Abstract

The goal of this study was to develop an injectable form of decellularized bovine myocardial tissue matrix which could retain high levels of functional ECM molecules, and could gel at physiological temperature. Dissected ventricular tissue was processed by a detergent-based protocol, lyophilized, enzymatically-digested, and neutralized to form the injectable myocardial matrix (IMM). Histochemical analysis, DNA quantification, and agarose gel electrophoresis demonstrated the efficiency of the applied protocol. Chemical, thermal, morphological, and rheological characterization; protein and sulfated glycosaminoglycan (sGAG) content analysis were performed, in vitro biological properties were evaluated. An in vivo histocompatibility and biodegradability study was performed. Histochemistry revealed complete removal of myocardial cells. DNA content analysis revealed a significant decrease (87%) in the nuclear material, while protein and sGAG contents were highly preserved following decellularization. Soluble IMM was capable of turning into gel form at ∼37 °C, indicating selfassembling property. In vitro findings showed the biomaterial was noncytotoxic, nonhemolytic, and supported the attachment and proliferation of mesenchymal stem cells. In vivo study demonstrated IMM was well-tolerated by rats receiving subcutaneous injection. This work demonstrates that the IMM from decellularized bovine myocardial tissue has the potential for use as a feasible regenerative biomaterial in prospective tissue engineering and regenerative medicine studies.


Corresponding author: Yaşar Murat Elçin, Biochemistry Division, Tissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Ankara University Faculty of Science, and Ankara University Stem Cell Institute, Tandogan, Ankara 06100, Turkey; and Biovalda Health Technologies, Inc., Ankara, Turkey, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

  4. Disclosure statement: Y.M.E. is the founder and shareholder of Biovalda Health Technologies, Inc. (Ankara, Turkey). A.E.E. and Y.M.E have patent applications in relation to regenerative biomaterials. The authors declare no competing financial interests in relation to this particular article.

References

1. Frantz, C, Stewart, KM, Weaver, VM. The extracellular matrix at a glance. J Cell Sci 2010;123:4195–200. https://doi.org/10.1242/jcs.023820.Search in Google Scholar

2. Mouw, JK, Ou, G, Weaver, VM. Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol 2014;15:771–85. https://doi.org/10.1038/nrm3902.Search in Google Scholar

3. Dogan, A, Parmaksiz, M, Elçin, AE, Elçin, YM. Extracellular matrix and regenerative therapies from the cardiac perspective. Stem Cell Rev Rep 2016;12:202–13. https://doi.org/10.1007/s12015-015-9641-5.Search in Google Scholar

4. Elçin, YM. Stem cells and tissue engineering. Adv Exp Med Biol 2004;553:301–16. https://doi.org/10.1007/978-0-306-48584-8_23.Search in Google Scholar

5. Patterson, J, Martino, MM, Hubbell, JA. Biomimetic materials in tissue engineering. Mater Today 2010;13:14–22. https://doi.org/10.1016/S1369-7021(10)70013-4.Search in Google Scholar

6. Nikolovaa, MP, Chavali, MS. Recent advances in biomaterials for 3D scaffolds: a review. Bioact Mater 2019;4:271–92. https://doi.org/10.1016/j.bioactmat.2019.10.005.Search in Google Scholar PubMed PubMed Central

7. Gaharwar, AK, Singh, I, Khademhosseini, A. Engineered biomaterials for in situ tissue regeneration. Nat Rev Mater 2020;5:686–705. https://doi.org/10.1038/s41578-020-0209-x.Search in Google Scholar

8. Badylak, SF, Taylor, D, Uygun, K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Ann Rev Biomed Eng 2011;13:27–53. https://doi.org/10.1146/annurev-bioeng-071910-124743.Search in Google Scholar PubMed

9. Parmaksiz, M, Dogan, A, Odabas, S, Elçin, AE, Elçin, YM. Clinical applications of decellularized extracellular matrices for tissue engineering and regenerative medicine. Topical review. Biomed Mater 2016;11:022003. https://doi.org/10.1088/1748-6041/11/2/022003.Search in Google Scholar PubMed

10. Hussey, GS, Dziki, JL, Badylak, SF. Extracellular matrix-based materials for regenerative medicine. Nat Rev Mater 2018;3:159–73. https://doi.org/10.1038/s41578-018-0023-x.Search in Google Scholar

11. Parmaksiz, M, Elçin, AE, Elçin, YM. Decellularization of bovine small intestinal submucosa and its use for the healing of a critical‐sized full‐thickness skin defect, alone and in combination with stem cells, in a small rodent model. J Tissue Eng Regen Med 2017;11:1754–65. https://doi.org/10.1002/term.2071.Search in Google Scholar

12. Parmaksiz, M, Elçin, AE, Elçin, YM. Decellularized bovine small intestinal submucosa-PCL/hydroxyapatite-based multilayer composite scaffold for hard tissue repair. Mater Sci Eng C Mater Biol Appl 2019;94:788–97. https://doi.org/10.1016/j.msec.2018.10.011.Search in Google Scholar

13. Ibsirlioglu, T, Elçin, AE, Elçin, YM. Decellularized biological scaffold and stem cells from autologous human adipose tissue for cartilage tissue engineering. Methods 2020;171:97–107. https://doi.org/10.1016/j.ymeth.2019.04.020.Search in Google Scholar

14. Parmaksiz, M, Elçin, AE, Elçin, YM. Decellularized cell culture ECMs act as cell differentiation inducers. Stem Cell Rev Rep 2020;16:569–84. https://doi.org/10.1007/s12015-020-09963-y.Search in Google Scholar

15. Zhang, Z. Injectable biomaterials for stem cell delivery and tissue regeneration. Expert Opin Biol Ther 2017;17:49–62. https://doi.org/10.1080/14712598.2017.1256389.Search in Google Scholar

16. Ercan, H, Durkut, S, Koç-Demir, A, Elçin, AE, Elçin, YM. Clinical applications of injectable biomaterials. Adv Exp Med Biol 2018;1077:163–82. https://doi.org/10.1007/978-981-13-0947-2_10.Search in Google Scholar

17. Liang, K, Bae, KH, Kurisawa, M. Recent advances in the design of injectable hydrogels for stem cell-based therapy. J Mater Chem B 2019;7:3775–91. https://doi.org/10.1039/c9tb00485h.Search in Google Scholar

18. Drury, JL, Money, DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003;24:4337–51. https://doi.org/10.1016/S0142-9612(03)00340-5.Search in Google Scholar

19. Tommasi, G, Perni, S, Prokopovich, P. An injectable hydrogel as bone graft material with added antimicrobial properties. Tissue Eng Part A 2016;22:862–72. https://doi.org/10.1089/ten.tea.2016.0014.Search in Google Scholar

20. Latifi, N, Asgari, M, Vali, H, Mongeau, L. A tissue-mimetic nano-fibrillar hybrid injectable hydrogel for potential soft tissue engineering applications. Sci Rep 2018;8:1047. https://doi.org/10.1038/s41598-017-18523-3.Search in Google Scholar PubMed PubMed Central

21. Pan, W, Dai, C, Li, Y, Yin, Y, Gong, L, Machuki, JO, et al.. PRP-chitosan thermoresponsive hydrogel combined with black phosphorus nanosheets as injectable biomaterial for biotherapy and phototherapy treatment of rheumatoid arthritis. Biomaterials 2020;239:119851. https://doi.org/10.1016/j.biomaterials.2020.119851.Search in Google Scholar PubMed

22. Saldin, LT, Cramer, MC, Velankar, SS, White, LJ, Badylak, SF. Extracellular matrix hydrogels from decellularized tissues: structure and function. Acta Biomater 2017;49:1–15. https://doi.org/10.1016/j.actbio.2016.11.068.Search in Google Scholar PubMed PubMed Central

23. Lin, CY, Liu, TY, Chen, MH, Sun, JS, Chen, MH. An injectable extracellular matrix for the reconstruction of epidural fat and the prevention of epidural fibrosis. Biomed Mater 2016;11:035010. https://doi.org/10.1088/1748-6041/11/3/035010.Search in Google Scholar PubMed

24. Pati, F, Jang, J, Ha, DH, Won Kim, S, Rhie, JW, Shim, JH, et al.. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun 2014;5:3935. https://doi.org/10.1038/ncomms4935.Search in Google Scholar PubMed PubMed Central

25. Liu, R, Zhang, S, Chen, X. Injectable hydrogels for tendon and ligament tissue engineering. J Tissue Eng Regen Med 2020;14:1333–48. https://doi.org/10.1002/term.3078.Search in Google Scholar PubMed

26. Singelyn, JM, Christman, KL. Modulation of material properties of a decellularized myocardial matrix scaffold. Macromol Biosci 2011;11:731–8. https://doi.org/10.1002/mabi.201000423.Search in Google Scholar PubMed PubMed Central

27. Johnson, TD, Dequach, JA, Gaetani, R, Ungerleider, J, Elhag, D, Nigam, V, et al.. Human versus porcine tissue sourcing for an injectable myocardial matrix hydrogel. Biomater Sci 2014;2014:60283D. https://doi.org/10.1039/C3BM60283D.Search in Google Scholar PubMed PubMed Central

28. Choi, Y-J, Jun, Y-J, Kim, DY, Yi, H-G, Chae, S-H, Kang, J, et al.. A 3D cell printed muscle construct with tissue-derived bioink for the treatment of volumetric muscle loss. Biomaterials 2019;206:160–9. https://doi.org/10.1016/j.biomaterials.2019.03.036.Search in Google Scholar PubMed

29. Wolf, MT, Daly, KA, Brennan-Pierce, EP, Johnson, SA, Carruthers, CA, D’Amore, A, et al.. A hydrogel derived from decellularized dermal extracellular matrix. Biomaterials 2012;33:7028–38. https://doi.org/10.1016/j.biomaterials.2012.06.051.Search in Google Scholar PubMed PubMed Central

30. Freytes, DO, Martin, J, Velankar, SS, Lee, AS, Badylak, SF. Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix. Biomaterials 2008;29:1630–7. https://doi.org/10.1016/j.biomaterials.2007.12.014.Search in Google Scholar PubMed

31. Seif-Naraghi, S, Salvatore, M, Schup-Magoffin, P, Hu, D, Christman, K. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A 2010;16:2017–27. https://doi.org/10.1089/ten.TEA.2009.0768.Search in Google Scholar PubMed PubMed Central

32. Wang, Z, Long, DW, Huang, Y, Chen, WCW, Kim, K, Wang, Y. Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction. Acta Biomater 2019;87:140–51. https://doi.org/10.1016/j.actbio.2019.01.062.Search in Google Scholar PubMed PubMed Central

33. Oberwallner, B, Brodarac, A, Choi, Y-H, Saric, T, Anic´, P, Morawietz, L, et al.. Preparation of cardiac extracellular matrix scaffolds by decellularization of human myocardium. J Biomed Mater Res Part A 2014;102A:3263–72. https://doi.org/10.1002/jbma.35000.Search in Google Scholar PubMed

34. Liu, ZZ, Wong, ML, Griffiths, LG. Effect of bovine pericardial extracellular matrix scaffold niche on seeded human mesenchymal stem cell function. Sci Rep 2016;6:37089. https://doi.org/10.1038/srep37089.Search in Google Scholar PubMed PubMed Central

35. ISO 10993-5:2009. Part 5: Tests for in vitro cytotoxicity. In: Biological evaluation of medical devices. Switzerland: International Organization for Standardization; 2009. p. 1–34.Search in Google Scholar

36. Massensini, AR, Ghuman, H, Saldin, LT, Medberry, CJ, Keane, TJ, Nicholls, FJ, et al.. Concentration-dependent rheological properties of ECM hydrogel for intracerebral delivery to a stroke cavity. Acta Biomater 2015;27:116–30. https://doi.org/10.1016/j.actbio.2015.08.040.Search in Google Scholar PubMed PubMed Central

37. Farndale, RW, Sayers, CA, Barrett, AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982;9:247–8. https://doi.org/10.3109/03008208209160269.Search in Google Scholar PubMed

38. ISO 10993-4:2017. Part 4: Selection of tests for interactions with blood. In: Biological evaluation of medical devices. Switzerland: International Organization for Standardization; 2017. p. 1–36.Search in Google Scholar

39. Çelebi, B, Elçin, YM. Proteome analysis of rat bone marrow mesenchymal stem cell subcultures. J Proteome Res 2009;8:2164–72. https://doi.org/10.1021/pr800590g.Search in Google Scholar PubMed

40. Çelebi, B, Elçin, AE, Elçin, YM. Proteome analysis of rat bone marrow mesenchymal stem cell differentiation. J Proteome Res 2010;9:5217–27. https://doi.org/10.1021/pr100506u.Search in Google Scholar PubMed

41. Baykan, E, Koç, A, Elçin, AE, Elçin, YM. Evaluation of a biomimetic poly(epsilon-caprolactone)/beta-tricalcium phosphate multispiral scaffold for bone tissue engineering: in-vitro and in-vivo studies. Biointerphases 2014;9:029011. https://doi.org/10.1116/1.4870781.Search in Google Scholar PubMed

42. Yan, C, Pochan, DJ. Rheological properties of peptide-based hydrogels for biomedical and other applications. Chem Soc Rev 2010;39:3528–40. https://doi.org/10.1039/b919449p.Search in Google Scholar PubMed PubMed Central

43. Seif-Naraghi, SB, Horn, D, Schup-Magoffin, PJ, Christman, KL. Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta Biomater 2012;8:3695–703. https://doi.org/10.1016/j.actbio.2012.06.030.Search in Google Scholar

44. Brightman, AO, Rajwa, BP, Sturgis, JE, McCallister, ME, Robinson, JP, Voytik-Harbin, SL. Time-lapse confocal reflection microscopy of collagen fibrillogenesis and extracellular matrix assembly in vitro. Biopolymers 2000;54:222–34. https://doi.org/10.1002/1097-0282(200009)54:3<222::AID-BIP80>3.0.CO;2-K.10.1002/1097-0282(200009)54:3<222::AID-BIP80>3.0.CO;2-KSearch in Google Scholar

45. Bao, J, Wu, Q, Sun, J, Zhou, Y, Wang, Y, Jiang, X, et al.. Hemocompatibility improvement of perfusion-decellularized clinical-scale liver scaffold through heparin immobilization. Sci Rep 2015;5:10756. https://doi.org/10.1038/srep10756.Search in Google Scholar

46. Wassenaar, JW, Gaetani, R, Garcia, JJ, Braden, RL, Luo, CG, Huang, D, et al.. Evidence for mechanisms underlying the functional benefits of a myocardial matrix hydrogel for post-MI treatment. J Am Coll Cardiol 2016;67:1074–86. https://doi.org/10.1016/j.jacc.2015.12.035.Search in Google Scholar

47. Koç, A, Finkenzeller, G, Elçin, AE, Stark, GB, Elçin, YM. Evaluation of adenoviral vascular endothelial growth factor-activated chitosan/hydroxyapatite scaffold for engineering vascularized bone tissue using human osteoblasts: in vitro and in vivo studies. J Biomater Appl 2014;29:748–60. https://doi.org/10.1177/0885328214544769.Search in Google Scholar

Received: 2021-02-11
Accepted: 2021-05-08
Published Online: 2021-05-27
Published in Print: 2021-11-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 26.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/znc-2021-0039/pdf
Scroll to top button